SCHEDULE 13D
Item 1. Security and Issuer
This Amendment No. 4 supplements and amends the Schedule 13D relating to shares of common stock, par value $0.001 per share (the “Common Stock”), of NGM Biopharmaceuticals, Inc., a Delaware corporation (the “Issuer”), that was filed with the Securities and Exchange Commission (the “SEC”) on April 12, 2019 as it has been amended by Amendment No. 1, Amendment No. 2 and Amendment No. 3 that were filed with the SEC on May 17, 2019, October 18, 2019 and April 2, 2020, respectively (collectively, the “Amended Statement”). Only those items that are reported are hereby amended; all other items reported in the Amended Statement remain unchanged. Capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Amended Statement. Information given in response to each item shall be deemed incorporated by reference in all other items as applicable.
Item 2. Identity and Background
Items 2(a), (b) and (c) of the Amended Statement are hereby amended and restated in their entirety as follows:
(a) This Schedule 13D is being filed by (i) The Column Group, LP, a Delaware limited partnership (“TCG LP”), (ii) The Column Group GP, LP, a Delaware limited partnership (“TCG GP”), (iii) The Column Group II, LP, a Delaware limited partnership (“TCG II LP”), (iv) The Column Group II GP, LP, a Delaware limited partnership (“TCG II GP”), (v) The Column Group Management LP, a Delaware limited partnership (“TCGM LP”), (vi) Ponoi Capital, LP, a Delaware limited partnership (“Ponoi LP”), (vii) Ponoi Management, LLC, a Delaware limited liability company (“Ponoi LLC”), (viii) Ponoi Capital II, LP, a Delaware limited partnership (“Ponoi II LP”), (ix) Ponoi II Management, LLC, a Delaware limited liability company (“Ponoi II LLC”), (x) The Column Group III, LP (“TCG III LP”), (xi) The Column Group III-A, LP (“TCG III-A LP”), (xii) The Column Group III GP, LP (“TCG III GP”), (xiii) The Column Group IV, LP (“TCG IV LP”), (xiv) The Column Group IV-A, LP (“TCG IV-A LP”), (xv) The Column Group IV GP, LP (“TCG IV GP LP”), (xvi) TCG IV GP LLC (“TCG IV LLC”) and (xvii) Peter Svennilson, David V. Goeddel and Tim Kutzkey (collectively referred to as the “Reporting Individuals”). Mr. Svennilson and Mr. Goeddel are the managing partners of TCG GP, TCG II GP and TCGM LP. Mr. Svennilson, Mr. Goeddel and Mr. Kutzkey are the managing members of Ponoi LLC, Ponoi II LLC, and TCG IV GP LLC, and the managing partners of TCG III GP. Each of the Reporting Individuals, TCG LP, TCG GP, TCG II LP, TCG II GP, TCGM LP, Ponoi LP, Ponoi LLC, Ponoi II LP, Ponoi II LLC, TCG III LP, TCG III-A LP, TCG III GP, TCG IV LP, TCG IV-A LP, TCG IV GP LP and TCG IV GP LLC are sometimes hereinafter referred to individually as a “Reporting Person,” and, collectively, as the “Reporting Persons.”
(b) The principal executive offices of TCG LP, TCG GP, TCG II LP, TCG II GP, TCGM LP, Ponoi LP, Ponoi LLC, Ponoi II LP, Ponoi II LLC, TCG III LP, TCG III-A LP, TCG III GP, TCG IV LP, TCG IV-A LP, TCG IV GP LP and TCG IV GP LLC and the business address of each of the Reporting Individuals is 1 Letterman Drive, Building D, Suite DM-900.
(c) The principal business of each of TCG LP, TCG II LP, Ponoi LP, Ponoi II LP, TCG III LP, TCG III-A LP, TCG IV LP and TCG IV-A LP is making venture capital investments. TCGM LP’s principal business is managing entities that make venture capital investments. TCG GP’s principal business is acting as general partner of TCG LP. TCG II GP’s principal business is acting as general partner of TCG II LP. Ponoi LLC’s principal business is acting as general partner of Ponoi LP. Ponoi II LLC’s principal business is acting as general partner of Ponoi II LP. TCG III GP’s principal business is acting as general partner of TCG III LP and TCG III-A LP. TCG IV GP LP’s principal business is acting as general partner of TCG IV LP and TCG IV-A LP. TCG IV GP LLC’s principal business is acting as general partner of TCG IV GP LP. Each Reporting Individual is engaged through venture capital investment entities in acquiring, holding and disposing of interests in various companies for investment purposes. Each of Mr. Svennilson’s and Mr. Goeddel’s principal business is acting as a managing partner of TCG GP, TCG II GP, TCGM LP, TCG III GP, and managing member of Ponoi LLC, Ponoi II LLC and TCG IV GP LLC. Mr. Kutzkey’s principal business is acting as a managing member of Ponoi LLC, Ponoi II LLC and TCG IV GP LLC, and managing partner of TCG III GP.
Item 3. Source and Amount of Funds or Other Consideration
Item 3 of the Amended Statement is hereby amended by adding the following as the last paragraph thereof:
On January 24, 2022, TCG IV LP purchased 241,750 shares of Common Stock in a block trade for an aggregate purchase price of $3,457,025.00.